A hospital staffer diverted drugs, and I got hepatitis C. Diversion is common
In hospitals and health systems across the country, workers divert painkillers and other drugs for their own use. More needs to be done about it.
Related Articles
Breakthrough therapies have given Duchenne muscular dystrophy families like mine hope — and new fears
Michelle C. Werner agonized over whether the gene therapy treatment Elevidys was right for her teenage son. But to him, the answer was obvious.
How Paralympic athletes are helping science learn more about neuropathic pain
Published in BMJ Open Sport and Exercise, the study looked at athletes with spinal cord injuries to better understand neuropathic pain.
With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights
Summit’s lung cancer treatment has wowed researchers. The CEO behind it is a living challenge to the assumptions of many in biotech.
Medicine struggles to define chronic Lyme. Long Covid has only made it harder
The overlapping symptoms of long Covid and persistent Lyme challenge patients and doctors alike. Researchers are seeking biomarkers and devising “cross-illness” trials.
She was told she might have cancer: How medicine pathologizes Black patients’ normal test results
Blood tests set to norms based on the physiology of white men can lead to misdiagnosis and unnecessary health scares for people of different races.
U.K. charities give $36 million to start new drugs for childhood tumors
Pediatric cancer treatments have been neglected. Two U.K. charities are starting a consortium to advance new molecules to a “drug candidate” stage, for handoff to…
5 burning questions about Missouri’s mysterious H5 bird flu case
Could raw milk — or a cat — help explain how a person who had no contact with animals caught H5 bird flu?
How UnitedHealth harnesses its physician empire to squeeze profits out of patients
The insurer UnitedHealth is using its unrivaled physician empire to enrich itself by milking Medicare Advantage.
Upending a longstanding paradigm, cardiologists embrace ZIP codes, not race, to predict heart risk
In a first, a new heart disease risk calculator uses social factors to try to make predictions more accurate.
Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients
A CRISPR-augmented stem cell transplant has shown preliminary evidence that it can delay relapse in some cancer patients.